Glenmede Trust’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-54
| Closed | -$1K | – | 1245 |
|
2020
Q3 | $1K | Sell |
54
-12
| -18% | -$222 | ﹤0.01% | 2317 |
|
2020
Q2 | $2K | Sell |
66
-29
| -31% | -$879 | ﹤0.01% | 2213 |
|
2020
Q1 | $5K | Hold |
95
| – | – | ﹤0.01% | 2662 |
|
2019
Q4 | $5K | Buy |
95
+29
| +44% | +$1.53K | ﹤0.01% | 2662 |
|
2019
Q3 | $4 | Buy |
66
+32
| +94% | +$2 | ﹤0.01% | 2682 |
|
2019
Q2 | $2 | Hold |
34
| – | – | ﹤0.01% | 2831 |
|
2019
Q1 | $2 | Hold |
34
| – | – | ﹤0.01% | 2808 |
|
2018
Q4 | $1 | Buy |
+34
| New | +$1 | ﹤0.01% | 2857 |
|
2017
Q3 | – | Sell |
-398,691
| Closed | -$19.7M | – | 2729 |
|
2017
Q2 | $19.7M | Hold |
398,691
| – | – | 0.09% | 291 |
|
2017
Q1 | $19.7M | Buy |
398,691
+17,660
| +5% | +$873K | 0.09% | 291 |
|
2016
Q4 | $23.1M | Buy |
381,031
+247,538
| +185% | +$15M | 0.13% | 266 |
|
2016
Q3 | $8.86M | Buy |
+133,493
| New | +$8.86M | 0.05% | 376 |
|
2015
Q4 | – | Sell |
-239,113
| Closed | -$9.45M | – | 2648 |
|
2015
Q3 | $9.45M | Buy |
+239,113
| New | +$9.45M | 0.07% | 345 |
|